BTIG Research began coverage on shares of Netskope (NASDAQ:NTSK – Free Report) in a research report released on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $27.00 price objective on the stock.
A number of other equities analysts also recently commented on the company. Mizuho started coverage on Netskope in a research report on Monday. They set an “outperform” rating and a $25.00 price objective for the company. Morgan Stanley started coverage on Netskope in a research note on Monday. They set an “overweight” rating and a $27.00 target price for the company. BMO Capital Markets started coverage on Netskope in a research note on Monday. They set an “outperform” rating and a $26.00 target price for the company. UBS Group set a $27.00 target price on Netskope in a research note on Monday. Finally, Citigroup started coverage on Netskope in a research note on Monday. They set an “outperform” rating for the company. Sixteen analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $26.94.
View Our Latest Report on Netskope
Netskope Stock Up 1.8%
Insiders Place Their Bets
In other news, Director William J.G. Griffith acquired 2,000,000 shares of Netskope stock in a transaction on Friday, September 19th. The stock was bought at an average price of $19.00 per share, for a total transaction of $38,000,000.00. Following the completion of the purchase, the director owned 11,238,175 shares in the company, valued at $213,525,325. This represents a 21.65% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Netskope Company Profile
We are redefining security and networking for the era of cloud and AI. The cloud and AI have completely revolutionized work. We are more dispersed, more productive, and more automated than ever before, and the rate of change is only accelerating. Not since the internet has there been such a transformative tectonic shift.
Further Reading
- Five stocks we like better than Netskope
- What is a penny stock? A comprehensive guide
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Are Dividend Contenders? Investing in Dividend Contenders
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Using the MarketBeat Stock Split Calculator
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Netskope Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netskope and related companies with MarketBeat.com's FREE daily email newsletter.